These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 378368)

  • 21. Synthesis and identification of products derived from the metabolism of the carcinostatic 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea by rat liver microsomes.
    May HE; Kohlhepp SJ; Boose RB; Reed DJ
    Cancer Res; 1979 Mar; 39(3):762-72. PubMed ID: 427763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fluorescence determination of 5-fluorouracil and 1-(tetrahydro-2-furanyl)-5-fluorouracil in blood serum by high-performance liquid chromatography.
    Iwamoto M; Yoshida S; Hirose S
    J Chromatogr; 1984 Sep; 310(1):151-7. PubMed ID: 6438145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Studies on the composition and stability constant of inclusion complexes of beta-cyclodextrin with fluorouracil and ftorafur by NMR].
    Wen JQ; Cui W
    Yao Xue Xue Bao; 1990; 25(5):345-8. PubMed ID: 2284953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of tRNA 5-methyluridine methyltransferase and pseudouridine synthetase activities in 5-fluorouracil and 1-(tetrahydro-2-furanyl)-5-fluorouracil (ftorafur)-treated Escherichia coli.
    Frendewey DA; Kladianos DM; Moore VG; Kaiser II
    Biochim Biophys Acta; 1982 Apr; 697(1):31-40. PubMed ID: 6805514
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sensitive MS/MS-liquid chromatography assay for simultaneous determination of tegafur, 5-fluorouracil and 5-fluorodihydrouracil in plasma.
    Remaud G; Boisdron-Celle M; Morel A; Gamelin A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Sep; 824(1-2):153-60. PubMed ID: 16061432
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Stability and detection of metabolites of barbiturates: 2-oxo tetrahydro-3-furoic acids].
    Cavé C; Lafont O; Miocque M
    Ann Pharm Fr; 1988; 46(2):111-9. PubMed ID: 3214097
    [No Abstract]   [Full Text] [Related]  

  • 27. High-pressure liquid chromatographic analysis of ftorafur and its metabolites in biological fluids.
    Benvenuto JA; Lu K; Loo TL
    J Chromatogr; 1977 Apr; 134(1):219-22. PubMed ID: 323272
    [No Abstract]   [Full Text] [Related]  

  • 28. Metabolites of 5-fluorouracil in plasma and urine, as monitored by 19F nuclear magnetic resonance spectroscopy, for patients receiving chemotherapy with or without methotrexate pretreatment.
    Hull WE; Port RE; Herrmann R; Britsch B; Kunz W
    Cancer Res; 1988 Mar; 48(6):1680-8. PubMed ID: 3125967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical experiences with UFD-1].
    Furue H
    Gan To Kagaku Ryoho; 1982 Apr; 9(4):672-4. PubMed ID: 6820905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic activation of ftorafur [R,S-1-(tetrahydro-2-furanyl)-5-fluorouracil]: the microsomal oxidative pathway.
    El Sayed YM; Sadée W
    Biochem Pharmacol; 1982 Sep; 31(18):3006-8. PubMed ID: 6814451
    [No Abstract]   [Full Text] [Related]  

  • 31. Synthesis and characterization of hydroxylated mesocarb metabolites for doping control.
    Vahermo M; Suominen T; Leinonen A; Yli-Kauhaluoma J
    Arch Pharm (Weinheim); 2009 Apr; 342(4):201-9. PubMed ID: 19340833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biotransformation of hexapropymate in man. Part 2: Isolation and identification of metabolites.
    Leyssens L; van Boven M; Daenens P
    Pharmazie; 1984 Feb; 39(2):114-7. PubMed ID: 6718477
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Norethynodrel metabolites in human plasma and urine.
    Cook CE; Twine ME; Tallent CR; Wall ME; Bressler RC
    J Pharmacol Exp Ther; 1972 Oct; 183(1):197-205. PubMed ID: 5080031
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The metabolism of ftorafur in the beagle dog and rhesus monkey.
    Freudenthal RI; Emmerling DC
    Xenobiotica; 1977 Dec; 7(12):757-64. PubMed ID: 414463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure determination of metabolites of rilmazafone, a 1H-1,2,4-triazolyl benzophenone derivative in monkey urine.
    Koike M; Norikura R; Iwatani K; Sugeno K; Takahashi S; Nakagawa Y
    Xenobiotica; 1988 Mar; 18(3):257-68. PubMed ID: 3381539
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Biotransformation and Stability of Hydrocotarnine and Diazocarbonylhydrocotarnine and -hydrohydrastinine derivatives (author's transl)].
    Göber B; Pfeifer S; Pankow K; Kraft R
    Pharmazie; 1979 Dec; 34(12):830-7. PubMed ID: 545353
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Studies in vivo and in vitro on the influence of 5-fluorouracil and n'-(2'-furanidyl)-5-fluorouracil on the walker carcinosarcoma 256 in the rat (author's transl)].
    Mattern J; Volm M; Wayss K; Weber N
    Arzneimittelforschung; 1980; 30(6):981-4. PubMed ID: 6774738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies of antitumor agents. 1. Resolution of racemic 1-(tetrahydro-2-furanyl)-k-fluorouracil into the R and S isomers and examination of the biological activities of the isomers.
    Yasumoto M; Moriyama A; Unemi N; Hashimoto S; Suzue T
    J Med Chem; 1977 Dec; 20(12):1592-4. PubMed ID: 338900
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo formation of aromatic hydroxylated metabolites of 3,4-(methylenedioxy)methamphetamine in the rat: identification by ion trap tandem mass spectrometric (MS/MS and MS/MS/MS) techniques.
    Lim HK; Foltz RL
    Biol Mass Spectrom; 1991 Nov; 20(11):677-86. PubMed ID: 1686830
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of Ftorafue [R,S-1-(tetrahydro-2-furanyl)-5-fluorouracil] to 5-fluorouracil and gamma-butyrolactone.
    Au JL; Sadée W
    Cancer Res; 1980 Aug; 40(8 Pt 1):2814-9. PubMed ID: 6771006
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.